LinkedIn is testing Creator Discovery inside its Creator Marketplace, with broader availability expected in early 2027. The beta lets marketers filter creators by industry, job function, content type, audience demographics and LinkedIn Top Voice status before using formats such as Thought Leader Ads and BrandLink. LinkedIn explained the product on 28 September 2026.

LinkedIn says 63% of B2B buyers rely on creators early in the buying process and more than half return to creator content later to validate a decision. These are platform-reported findings, not independent guarantees of campaign performance.

Expertise becomes a media input

B2B creator marketing is different from buying reach from a general influencer. The value comes from professional credibility, a relevant audience and lived experience with the problem being discussed. Discovery filters can reduce research time, but they cannot verify every claim or prove that a creator will influence revenue.

Paid amplification also changes the relationship. A brand can extend a practitioner’s post beyond the creator’s organic following, while the creator’s identity remains central to the ad. That makes disclosure, editorial control and permission especially important.

Healthcare and GCC relevance

Healthcare buyers often need trust from clinicians, operators and procurement leaders before they consider a service or technology. In Saudi Arabia and the UAE, the strongest creators may be bilingual experts with smaller but highly relevant professional networks. Medical content still requires evidence, disclosure and local regulatory review.

Karim’s strategic takeaway

Build a pilot around three credible voices: a clinician, an operator and a business leader. Select them by audience relevance and subject expertise rather than follower count. Sponsor only posts that have passed clinical and brand review, then measure qualified meetings, sales-pipeline progression and cost per meaningful conversation instead of impressions alone.